Skip to main content
. Author manuscript; available in PMC: 2017 Jul 25.
Published in final edited form as: Angew Chem Int Ed Engl. 2016 Jun 8;55(31):8913–8917. doi: 10.1002/anie.201602974

Table 2.

IC50 values of the amide-bridged AIP analogues against AgrCs I–IV determined using S. aureus fluorescence reporter strains.[a]

Peptide name Inhibition (IC50nM)[b]

AgrC-I AgrC-II AgrC-III AgrC-IV
AIP-III Amide >1000 >1000 75.2 299
AIP-III D4A Amide 1.20 2.19 0.0551 0.192
tAIP-III D2A Amide 1.50 13.9 0.216 0.189
AIP-III[c] 5.05 5.63 -[d] 8.53
AIP-III D4A[c] 0.485 0.429 0.0506 0.0349
tAIP-III D2A[c] 0.257 0.900 0.329 0.0957
a

See SI for details of reporter strains and methods, and antagonism dose response curves.

b

See SI for 95% confidence ranges.

c

Control peptides, data from ref.[6a].

d

Receptor agonist.